• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌细针穿刺抽吸物及组织切片中雌激素受体免疫细胞化学检测与生化检测的比较

Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.

作者信息

Katz R L, Patel S, Sneige N, Fritsche H A, Hortobagyi G N, Ames F C, Brooks T, Ordonez N G

机构信息

Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Breast Cancer Res Treat. 1990 May;15(3):191-203. doi: 10.1007/BF01806356.

DOI:10.1007/BF01806356
PMID:1695528
Abstract

An immunocytochemical assay using a monoclonal antibody specific for estrogen receptor (ER-ICA) was performed on needle aspirates and on histologic sections (mastectomy and biopsy specimens) from 55 patients with breast cancer. A total of 82 ER-ICAs were performed, with matched cytologic and histologic specimens in 27 patients, cytology alone in 15, and histology alone in 13. ER-ICA results were described by a histochemical score (H score) based on intensity-weighted percentages of staining cells. The H scores were compared with results of sucrose density gradient (SDG) analysis of histologic specimens (mastectomy, resection, or biopsy). An H score greater than or equal to 10 and an SDG value greater than or equal to 10 fmol/mg protein were considered positive. The sensitivity of cytologic ER-ICA was 94%, the specificity 100%. The sensitivity of histologic ER-ICA was 67%, the specificity 90%. Correlating cytologic H score with Black's nuclear grade showed that grade 1 (the most anaplastic) carcinomas demonstrated the lowest H scores (mean, 7.3 +/- 29.8), whereas the highest H scores were noted in grade 3 tumors (mean, 150.0 +/- 88.1). Both SDG and ER-ICA showed ER values to be lower in premenopausal than postmenopausal women. There was no correlation between H score and presence of axillary nodal metastases or tumor size. An overall good correlation was demonstrated between immunohistochemical methods and biochemical analysis.

摘要

对55例乳腺癌患者的针吸活检样本以及组织学切片(乳房切除术和活检标本)进行了雌激素受体特异性单克隆抗体免疫细胞化学检测(ER-ICA)。共进行了82次ER-ICA检测,其中27例患者的细胞样本与组织样本相匹配,15例仅进行了细胞学检测,13例仅进行了组织学检测。ER-ICA结果通过基于染色细胞强度加权百分比的组织化学评分(H评分)来描述。将H评分与组织学标本(乳房切除术、切除术或活检)的蔗糖密度梯度(SDG)分析结果进行比较。H评分大于或等于10且SDG值大于或等于10 fmol/mg蛋白被视为阳性。细胞学ER-ICA的敏感性为94%,特异性为100%。组织学ER-ICA的敏感性为67%,特异性为90%。将细胞学H评分与布莱克核分级相关联显示,1级(最间变)癌的H评分最低(平均值为7.3±29.8),而3级肿瘤的H评分最高(平均值为150.0±88.1)。SDG和ER-ICA均显示绝经前女性的ER值低于绝经后女性。H评分与腋窝淋巴结转移的存在或肿瘤大小之间无相关性。免疫组织化学方法与生化分析之间显示出总体良好的相关性。

相似文献

1
Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas.乳腺癌细针穿刺抽吸物及组织切片中雌激素受体免疫细胞化学检测与生化检测的比较
Breast Cancer Res Treat. 1990 May;15(3):191-203. doi: 10.1007/BF01806356.
2
Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.人乳腺癌活检组织及细针穿刺抽吸物的雌激素受体分析。使用单克隆抗受体抗体的生化方法与免疫组化方法的相关性。
Am J Pathol. 1986 Dec;125(3):443-9.
3
Estrogen receptor immunocytochemical assay on cytologic material from primary and metastatic breast cancer.对原发性和转移性乳腺癌细胞材料进行雌激素受体免疫细胞化学检测。
Pathology. 1989 Apr;21(2):93-9. doi: 10.3109/00313028909059543.
4
Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer.雌激素受体免疫细胞化学用于术前确定乳腺癌细针穿刺抽吸物的雌激素受体状态。
Am J Clin Pathol. 1987 Oct;88(4):399-404. doi: 10.1093/ajcp/88.4.399.
5
Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors.
Cancer. 1987 Sep 15;60(6):1163-72. doi: 10.1002/1097-0142(19870915)60:6<1163::aid-cncr2820600602>3.0.co;2-d.
6
Estrogen receptor determination in fine needle aspirates of the breast. Correlation with histologic grade and comparison with biochemical analysis.乳腺细针穿刺抽吸物中雌激素受体的测定。与组织学分级的相关性及与生化分析的比较。
Acta Cytol. 1987 Sep-Oct;31(5):557-62.
7
[Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].乳腺癌中雌激素受体的免疫组织化学检测及图像分析(SAMBA 200)
Ann Pathol. 1988;8(3):196-210.
8
Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
Diagn Cytopathol. 1990;6(2):95-8. doi: 10.1002/dc.2840060205.
9
Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Cancer Res. 1988 Mar 15;48(6):1578-86.
10
Estrogen receptor immunocytochemical assay (ERICA) and laminin detection in 130 breast carcinomas and computerized (Samba 200) multiparametric quantitative analysis on tissue sections.
Bull Cancer. 1986;73(6):651-64.

引用本文的文献

1
Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.早期胃腺癌患者的腹腔镜分期和腹腔细胞学检查。
World J Surg Oncol. 2020 Feb 17;18(1):39. doi: 10.1186/s12957-020-01813-y.
2
Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer.跨膜蛋白 CD151 是预后不良型子宫内膜癌的新型预后标志物。
Br J Cancer. 2011 May 10;104(10):1611-8. doi: 10.1038/bjc.2011.80. Epub 2011 Apr 19.
3
A profile of prognostic and molecular factors in European and Māori breast cancer patients.

本文引用的文献

1
Nuclear structure in cancer tissues.癌组织中的核结构。
Surg Gynecol Obstet. 1957 Jul;105(1):97-102.
2
The value of estrogen and progesterone receptors in the treatment of breast cancer.雌激素和孕激素受体在乳腺癌治疗中的价值。
Cancer. 1980 Dec 15;46(12 Suppl):2884-8. doi: 10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u.
3
Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.雌激素受体与浸润性乳腺癌病理特征的相关性
欧洲和毛利乳腺癌患者的预后和分子因素特征分析。
BMC Cancer. 2010 Oct 10;10:543. doi: 10.1186/1471-2407-10-543.
4
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.基于新辅助内分泌治疗后肿瘤特征的雌激素受体阳性乳腺癌预后预测
J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.
5
pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.pS2蛋白:一种可改善绝经后乳腺癌患者对新辅助他莫昔芬反应预测的标志物。
Br J Cancer. 1996 Oct;74(7):1120-5. doi: 10.1038/bjc.1996.500.
6
Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.他莫昔芬治疗下乳腺癌中激素受体、pS2、c-erbB-2和谷胱甘肽S-转移酶π含量的变化:74例研究
Br J Cancer. 1996 Mar;73(6):735-43. doi: 10.1038/bjc.1996.129.
7
Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.
Breast Cancer Res Treat. 1994;32(2):221-8. doi: 10.1007/BF00665773.
8
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods.
Breast Cancer Res Treat. 1995 Jun;34(3):221-8. doi: 10.1007/BF00689713.
Cancer. 1980 Jan 15;45(2):349-53. doi: 10.1002/1097-0142(19800115)45:2<349::aid-cncr2820450226>3.0.co;2-p.
4
Monoclonal antibodies to human estrogen receptor.抗人雌激素受体单克隆抗体。
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5115-9. doi: 10.1073/pnas.77.9.5115.
5
Influence of surgical technique on estrogen and progesterone receptor determinations in breast cancer.手术技术对乳腺癌雌激素和孕激素受体测定的影响。
Cancer. 1983 Jun 15;51(12):2317-20. doi: 10.1002/1097-0142(19830615)51:12<2317::aid-cncr2820511225>3.0.co;2-e.
6
Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.手术去血管化对乳腺癌标本中雌激素和孕激素受体水平的影响。
Surgery. 1985 Oct;98(4):784-91.
7
Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Correlation with biochemistry and clinical endocrine response.用单克隆抗体对乳腺癌中雌激素受体进行免疫组织学定位。与生物化学及临床内分泌反应的相关性。
Cancer. 1985 Apr 1;55(7):1513-8. doi: 10.1002/1097-0142(19850401)55:7<1513::aid-cncr2820550717>3.0.co;2-4.
8
Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.人乳腺肿瘤中雌激素受体免疫细胞化学检测与类固醇结合检测的比较
Cancer Res. 1985 Jan;45(1):293-304.
9
Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies.使用单克隆抗雌激素受体抗体评估细针穿刺乳腺活检组织中的雌激素受体含量。
Ann Surg. 1986 Mar;203(3):250-4. doi: 10.1097/00000658-198603000-00005.
10
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.雌激素受体分析。使用单克隆抗受体抗体的生化方法与免疫组织化学方法的相关性。
Arch Pathol Lab Med. 1985 Aug;109(8):716-21.